These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17636541)

  • 1. Antibody responses to survivin and their clinical significance in patients with head and neck cancer.
    Eto M; Kodama S; Uemura N; Suzuki M
    Head Neck; 2007 Dec; 29(12):1128-35. PubMed ID: 17636541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between anti-survivin antibody and survivin mRNA expression in head and neck cancer patients.
    Uemura N; Kodama S; Nomi N; Okamoto T; Suzuki M
    Acta Otolaryngol; 2010 Aug; 130(8):959-65. PubMed ID: 20100132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.
    Yagihashi A; Ohmura T; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Hirata K; Watanabe N
    Clin Chim Acta; 2005 Dec; 362(1-2):125-30. PubMed ID: 16026775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.
    Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Shijubo Y; Abe S; Hirohashi Y; Torigoe T; Sato N; Watanabe N
    Lung Cancer; 2005 May; 48(2):217-21. PubMed ID: 15829321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new prognostic indicator for head and neck cancer--p53 serum antibodies?
    Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Werner JA
    Anticancer Res; 1999; 19(4A):2703-5. PubMed ID: 10470224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection.
    Megliorino R; Shi FD; Peng XX; Wang X; Chan EK; Tan EM; Zhang JY
    Cancer Detect Prev; 2005; 29(3):241-8. PubMed ID: 15896923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H; Sen S; Mathur M; Bahadur S; Singh N
    Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy.
    Kitamura H; Torigoe T; Honma I; Asanuma H; Nakazawa E; Shimozawa K; Hirohashi Y; Sato E; Sato N; Tsukamoto T
    Urology; 2006 May; 67(5):955-9. PubMed ID: 16635519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 autoantibodies as tumor marker in head and neck squamous cell cancer.
    Gottschlich S; Hoffmann M; Maass JD; Görörgh T; Buhmann V; Hoffmann-Fazel A; Rudert H; Maune S
    Anticancer Res; 2003; 23(2A):913-5. PubMed ID: 12820322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.
    Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Watanabe N
    Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and neck cancer and p53-immunogenicity.
    Maass JD; Gottschlich S; Goeroegh T; Lippert BM; Werner JA
    Anticancer Res; 1997; 17(4B):2873-4. PubMed ID: 9329551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients.
    Rohayem J; Diestelkoetter P; Weigle B; Oehmichen A; Schmitz M; Mehlhorn J; Conrad K; Rieber EP
    Cancer Res; 2000 Apr; 60(7):1815-7. PubMed ID: 10766164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-survivin antibody responses in lung cancer.
    Karanikas V; Khalil S; Kerenidi T; Gourgoulianis KI; Germenis AE
    Cancer Lett; 2009 Sep; 282(2):159-66. PubMed ID: 19380192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
    Eibling DE; Johnson JT; Wagner RL; Su S
    Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of p53 antibody response in patients with squamous cell carcinoma of the head and neck.
    Lavieille JP; Lubin R; Soussi T; Reyt E; Brambilla C; Riva C
    Anticancer Res; 1996; 16(4C):2385-8. PubMed ID: 8816839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.